Dermata Therapeutics, Inc. (DRMA)
NASDAQ·Healthcare·Biotechnology
$1.24
+2.48%
Mkt Cap $903.06K
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 26, 2026 | — | — | — | -$1.54 | -$1.52 | +1.30% | — | — |
| Q4 2025 Nov 14, 2025 | — | — | — | -$1.59 | -$1.65 | -3.77% | — | — |
| Q3 2025 Aug 13, 2025 | — | — | — | -$2.90 | -$1.66 | +42.76% | — | — |
| Q2 2025 May 14, 2025 | — | — | — | -$0.45 | -$4.50 | -900.00% | — | — |
| Q1 2025 Mar 17, 2025 | — | — | — | -$1.50 | -$3.15 | -110.00% | — | — |
| Q4 2024 Nov 13, 2024 | — | — | — | -$2.64 | -$2.04 | +22.73% | — | — |
| Q3 2024 Aug 7, 2024 | — | — | — | -$3.79 | -$4.18 | -10.29% | — | — |
| Q2 2024 May 15, 2024 | — | — | — | -$5.40 | -$7.05 | -30.56% | — | — |
| Q1 2024 Mar 21, 2024 | — | — | — | -$0.78 | -$3.15 | -303.85% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.63 | -$8.10 | -1185.71% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.92 | -$9.45 | -927.17% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$2.65 | -$34.03 | -1184.15% | — | — |
| Q1 2023 Feb 21, 2023 | — | — | — | $3.20 | -$28.79 | -999.69% | — | — |
| Q4 2022 Nov 10, 2022 | — | — | — | -$3.52 | -$47.98 | -1263.07% | — | — |
| Q3 2022 Aug 15, 2022 | — | — | — | -$5.12 | -$57.57 | -1024.41% | — | — |
| Q2 2022 May 16, 2022 | — | — | — | -$6.40 | -$79.16 | -1136.87% | — | — |
| Q1 2022 Mar 28, 2022 | — | — | — | -$5.68 | -$4.16 | +26.76% | — | — |
| Q4 2021 Nov 15, 2021 | — | — | — | -$7.36 | -$13.76 | -86.96% | — | — |
| Q3 2021 Sep 27, 2021 | — | — | — | -$22.56 | -$11.20 | +50.35% | — | — |
| Q3 2021 Aug 16, 2021 | — | — | — | — | -$4.43 | — | — | — |